David Hirsch, Alpha-9 Oncology CEO
October 23, 2024 10:58 AM EDT
Financing
Startups

Ra­dio­phar­ma star­tups stay hot as Al­pha-9 bags $175M Se­ries C

Max Gelman

Senior Editor

An­oth­er pri­vate ra­dio­phar­ma­ceu­ti­cal biotech has raised big mon­ey.

Al­pha-9 On­col­o­gy re­vealed on Wednes­day that it’s put to­geth­er a $175 mil­lion Se­ries …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times